Evidence map›Paper›PMID 40070759›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025

Utilizing Narrow Band Imaging for Early Detection of Recurrence in Follow-Up Patients with Head and Neck Squamous Cell Carcinoma Treated with Curative Intent Using Radiotherapy/Chemo-Radiotherapy: Enhancing Detection and Patient Outcomes.

Vikas Gupta, V S Sreejith, S K Singh, Rajeev Chugh, Himanshu Swami, Abha Kumari, Varun Jerath

Abstract read
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vikas GuptaDepartment of ORL-HNS, Army Hospital (Research & Referral), Delhi Cantt, Delhi, 110010 India.ORCID 0000-0002-1739-3993
V S SreejithDepartment of ORL-HNS, Army Hospital (Research & Referral), Delhi Cantt, Delhi, 110010 India.
S K SinghDepartment of ORL-HNS, Army Hospital (Research & Referral), Delhi Cantt, Delhi, 110010 India.
Rajeev ChughDepartment of ORL-HNS, Army Hospital (Research & Referral), Delhi Cantt, Delhi, 110010 India.
Himanshu SwamiDepartment of ORL-HNS, Army Hospital (Research & Referral), Delhi Cantt, Delhi, 110010 India.
Abha KumariDepartment of ORL-HNS, Army Hospital (Research & Referral), Delhi Cantt, Delhi, 110010 India.
Varun JerathDepartment of ORL-HNS, Army Hospital (Research & Referral), Delhi Cantt, Delhi, 110010 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and Neck squamous cell carcinoma (HNSCC) is one of the most common cancer in developing countries. Most of the patients present with advanced disease and requires rigorous treatment. Routine follow up of the patient is required to detect any recurrence which will substantially affect overall survival of the patient. Narrow Band Imaging is one of the advanced endoscopic modalities which can be used for assessment of the patients during follow-up along with White light examination (WLE) and WB PETCT. An observational study to determine the efficacy and diagnostic accuracy of NBI in early detection of recurrence in follow-up patients with HNSCC was conducted comparing it with WLE, WB-PETCT and HPE. 60 patients who received definitive radiotherapy /Chemoradiotherapy (RT/CRT) for HNSCC were followed up for a period of 12 months with WLE, NBI, WB PETCT and was compared with HPE. NBI demonstrated higher sensitivity (95.45%) and specificity (97.37%) compared to WLE, which had sensitivity and specificity of 77.27% and 92.11%, respectively. NBI also had superior diagnostic accuracy (96.67%) versus white light (86.67%).WB-PETCT had sensitivity of 95.45% and specificity of 92.11% with a diagnostic accuracy of 93.33% for detecting local recurrences. NBI is a more sensitive and accurate tool for detecting early recurrences in HNSCC post RT/CRT, improving patient outcomes through timely intervention. Proper training and standardized interpretation protocols are essential for maximizing its clinical utility.

Indexed as

ChemoradiotherapyHNSCCNarrow Band ImagingRadiotherapyWB-PETCTWhite light examination

Identifiers

PMID40070759
PMCPMC11890879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.